BITOUN Lab

Muscle cell organization and therapy of dominant centronuclear myopathy

  Muscle cell organization and therapy of dominant centronuclear myopathy

Strengthening knowledge on fundamental aspects of muscle biology is one central challenge in order to decipher pathomechanisms and identify targets for therapeutic intervention for neuromuscular disorders. This is particularly true for diseases due to mutations in genes encoding proteins with pleiotropic roles such as autosomal dominant centronuclear myopathy (CNM) due to mutation of the ubiquitously expressed Dynamin 2 (DMN2) involved in endocytosis, intracellular membrane trafficking and cytoskeleton regulation. In this context, the objectives of the team are: i) to dissect fundamental mechanisms of muscle cells, relevant to understand the dominant CNM, and beyond, numerous other neuromuscular disorders, and ii) to develop experimental therapies for the dominant CNM and study the adeno-associated virus (AAV) vectors fate in pathological muscles to optimize AAV-mediated therapies for neuromuscular disorders. With these objectives, we are developing several projects:

– Role of the endocytosis machinery in mechanobiology at the costameres in healthy and pathological muscles with a particular focus on its adhesive properties and the interplay with mechanosensitive pathways. We also want to better understand how alternative splicing events of the endocytosis machinery cooperates, upon differentiation, to govern clathrin structural diversity (Stéphane Vassilopoulos).

– Role of mechanical stress in muscle homeostasis and growth under physiological and pathological conditions, with a particular focus on the force-mediated regulation of plasma membrane and nuclear stiffness and deformations, chromatin and histone modifications, and genetic programs in muscle cells. We also want to determine how muscle differentiation impacts nuclear characteristics (Catherine Coirault).

– The cellular and molecular mechanisms involved in ventilation-induced diaphragm dysfunction in particular during aging, and the muscle dysfunction occurring in patients in intensive care unit (Catherine Coirault and Adrien Bouglé).

– By combining genetic modifications, live imaging, biophysics, cellular and animal models, we aim at deciphering the pivotal influence of the nucleo-cytoskeleton connection on cell phenotype and genome organization in particular in the context of muscle formation and cardiomyopathy (Bruno Cadot).

– Preclinical development of the allele-specific silencing therapy for the dominant CNM and other DNM2-linked diseases and first proof of concept of allele-specific therapy for other dominant diseases. In addition, we want to develop pharmacological therapy for the DNM2-linked CNM patients (Delphine Trochet & Marc Bitoun).

– In order to optimize AAV-based therapies, we want to identify cellular factors impacting the efficiency of AAV-mediated transduction in diseased muscles. We are focusing on mechanisms regulating the AAV intracellular trafficking and to improve AAV-mediated therapies in DMD and CNM animal models by pharmacological co-treatments (Sofia Benkhelifa-Ziyyat).

Team members:

Equipe Bitoun - UMRS 974 - Centre de recherche en myologie
Marc Bitoun

Contact:

Marc Bitoun

NamePositionEmailORCID



185 documents

  • Clémence Labasse, Guy Brochier, Ana-Lia Taratuto, Bruno Cadot, John Rendu, et al.. Severe ACTA1-related nemaline myopathy: intranuclear rods, cytoplasmic bodies, and enlarged perinuclear space as characteristic pathological features on muscle biopsies. Acta Neuropathologica Communications, 2022, 10 (1), pp.101. ⟨10.1186/s40478-022-01400-0⟩. ⟨hal-03820052⟩
  • Stéphane Vassilopoulos. Caveolae and Bin1 for ring-shaped platforms for T-tubule initiation. Journées de la Société Française de Myologie, Nov 2022, Toulouse, France. ⟨hal-03920050⟩
  • Ines Akrouf, Julie Chassagne, Pierre Meunier, Zoheir Guesmia, Bruno Cadot, et al.. Modulation of intracellular pathways involved in the AAV trafficking to optimize AAV-based therapies in Duchenne muscular dystrophy and autosomal dominant Centronuclear Myopathy. Journées de la Société Française de Myologie, Nov 2022, Toulouse, France. 2022. ⟨hal-03946260⟩
  • C Gentil, A Vergnol, L Giordani, B Cadot, P Meunier, et al.. Combined treatment GDF5 and AAV-microDystrophin for Duchenne Muscular Dystrophy. Journées de la Société Française de Myologie, Nov 2022, Toulouse, France. 2022. ⟨hal-03944592⟩
  • A Jeannin-Girardon, P Collet, K Chennen, O Poch, Nb Romero, et al.. MYO-xIA : Quantification de marqueurs pathologiques sur coupes histologiques et exploitation de rapport de biopsie par intelligence artificielle explicative pour le diagnostic de myopathies congénitales. Journées de la Société Française de Myologie, Nov 2022, Toulouse, France. 2022. ⟨hal-03953252⟩
  • Sestina Falcone, Marais T., Traoré M., Bourguiba A., Gentil C., et al.. Unraveling the role of GDF5 therapeutic potential in Amyotrophic Lateral Sclerosis. 19 Journée de la societé Française de Myologie, Nov 2022, Toulouse (FR), France. ⟨hal-04002173⟩
  • Anne Cécile Durieux, David Arnould, Valentine Allibert, Cloé Paret, Pierre Pelliat, et al.. Targeting myostatin to improve skeletal muscle mass and function in a mouse model of Dnm2-related centronuclear myopathy. Journées de la Société Française de Myologie, Nov 2022, Toulouse, France. 2022. ⟨hal-03953238⟩
  • Cadot Bruno. Mechanical forces in striated muscles cells. Journées de la Société Française de Myologie, Nov 2022, Toulouse, France. ⟨hal-03921731⟩
  • Mark R Viggars, Daniel Owens, Claire Stewart, Catherine Coirault, Abigail L Mackey, et al.. PCM1 labelling reveals myonuclear and nuclear dynamics in skeletal muscle across species. American Journal of Physiology - Cell Physiology, 2022, Online ahead of print. ⟨10.1152/ajpcell.00285.2022⟩. ⟨inserm-03852473⟩
  • Saline Jabre. Impact of mechanical stress on nucleus morphology and transcription on skeletal muscle. Cellular Biology. Sorbonne Université; Université Saint-Esprit (Kaslik, Liban), 2022. English. ⟨NNT : 2022SORUS561⟩. ⟨tel-04317459⟩
Agence nationale de la recherche
Inserm Transfert
SU Emergence
Myotubular trust
USEK
Campus France

You cannot copy content of this page

Share This